Arch Chemicals Names Dr. Alex Valcke Vice President, Innovation

Dr. Alex Valcke will be joining Arch Chemicals as Vice President, Innovation, effective November 1, and reporting to Arch Chairman, President and CEO Michael E. Campbell.

In this capacity, he will work closely with Arch's senior management team and its businesses to ensure that Arch is pursuing and investing in the best R&D efforts that support the Company's business strategies. In addition, he will identify and drive cross-business as well as external technology opportunities.

Dr. Valcke comes to Arch after a 25-year career at Janssen Pharmaceutica NV (part of the Johnson & Johnson family of companies), where he most recently held the position of General Manager, Preservation and Material Protection Division. During his career at Janssen, he gained valuable experience as a business leader, managed key divestments and acquisitions for the division, and led a successful effort to significantly expand the company's new product portfolio. He is also an inventor and co-inventor for several patents in the field of material protection biocides and has experience in technology licensing.

"Alex Valcke brings to Arch the creative drive, the technology depth and the business breadth that will help lead us to the next level of innovation and growth," said Campbell. "His extensive background and experience in microbiology, new product development and wood technology is perfectly suited for Arch's core biocides portfolio."

Located in Antwerp, Belgium, Dr. Valcke will spend a substantial part of his time in the United States and at Arch technology centers and other locations around the globe.

Arch Chemicals, Inc. is a global biocides company with approximately $1.5 billion in annual sales.

((Comments on this story may be sent to newsdesk@closeupmedia.com))

Related terms: acquisition, belgium, business, career, ceo, chemicals, family, new product, president, technology